Literature DB >> 21777975

Mass eradication of Helicobacter pylori: feasible and advisable?

Luiz Edmundo Mazzoleni1, Carlos Fernando Francesconi, Guilherme Becker Sander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21777975     DOI： 10.1016/S0140-6736(11)61099-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Haem oxygenase-1 inhibits phosphorylation of the Helicobacter pylori oncoprotein CagA in gastric epithelial cells.

Authors:  Alain P Gobert; Thomas Verriere; Thibaut de Sablet; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson
Journal:  Cell Microbiol       Date:  2012-11-07       Impact factor: 3.715

2.  Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Authors:  Meira Epplein; Wei-Cheng You; Julia Butt; Yang Zhang; Laura H Hendrix; Christian C Abnet; Gwen Murphy; Wei Zheng; Xiao-Ou Shu; Shoichiro Tsugane; You-Lin Qiao; Philip R Taylor; Taichi Shimazu; Keun-Young Yoo; Sue K Park; Jeongseon Kim; Sun Ha Jee; Tim Waterboer; Michael Pawlita; Kai-Feng Pan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-29       Impact factor: 4.254

3.  The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

Authors:  Yi-Chia Lee; Tony Hsiu-Hsi Chen; Han-Mo Chiu; Chia-Tung Shun; Hung Chiang; Tzeng-Ying Liu; Ming-Shiang Wu; Jaw-Town Lin
Journal:  Gut       Date:  2012-06-14       Impact factor: 23.059

4.  Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates.

Authors:  J Vanderpas; P Bontems; V Y Miendje Deyi; S Cadranel
Journal:  Epidemiol Infect       Date:  2013-06-28       Impact factor: 4.434
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.